FKBP4 and prostate carcinoma: A significant increase (2.5-fold) in luciferase activity was observed in the prostate cancer cell line LNCaP, transfected with the FKBP4 promoter-luciferase vector compared to cells transfected with the empty reporter vector (Fig. 5c).